PetMed Express, Inc. (PETS)

USD 5.28

(-5.38%)

Total Debt Summary of PetMed Express, Inc.

  • PetMed Express, Inc.'s latest annual total debt in 2024 was 1.45 Million USD , down 0.0% from previous year.
  • PetMed Express, Inc.'s latest quarterly total debt in 2024 FY was 1.45 Million USD , down 0.0% from previous quarter.
  • PetMed Express, Inc. reported annual total debt of - USD in 2023, down 0.0% from previous year.
  • PetMed Express, Inc. reported annual total debt of - USD in 2022, down 0.0% from previous year.
  • PetMed Express, Inc. reported quarterly total debt of 2.06 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • PetMed Express, Inc. reported quarterly total debt of 1.83 Million USD for 2024 Q2, down -11.13% from previous quarter.

Annual Total Debt Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Total Debt of PetMed Express, Inc. (2024 - 2000)

Year Total Debt Total Debt Growth
2024 1.45 Million USD 0.0%
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD -100.0%
2004 68.44 Thousand USD -50.0%
2003 136.88 Thousand USD -60.5%
2002 346.54 Thousand USD -82.28%
2001 1.95 Million USD -31.02%
2000 2.83 Million USD 0.0%

Peer Total Debt Comparison of PetMed Express, Inc.

Name Total Debt Total Debt Difference
CannBioRx Life Sciences Corp. 1.32 Million USD -10.146%
BIMI International Medical Inc. 5.45 Million USD 73.347%
China Jo-Jo Drugstores, Inc. 43.21 Million USD 96.636%
Harrow Health, Inc. 8.625% Senior Notes due 2026 190.5 Million USD 99.237%
Harrow Health, Inc. 11.875% Senior Notes due 2027 183.17 Million USD 99.206%
Leafly Holdings, Inc. 29.08 Million USD 95.001%
Leafly Holdings, Inc. 29.08 Million USD 95.001%
LifeMD, Inc. 18.93 Million USD 92.32%
LifeMD, Inc. 18.93 Million USD 92.32%
TRxADE HEALTH, Inc. 7.1 Million USD 79.532%
Walgreens Boots Alliance, Inc. 9.55 Billion USD 99.985%